Tejada, Jomie E.
HRN: 19-58-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2024
CEFTAZIDIME 1GM (VIAL)
01/03/2024
01/09/2024
IVTT
1g
Q8
Cap-MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes